Invesco Exchange-Traded Fund Trust II - Invesco Nasdaq Biotechnology ETF

SecurityIBBQ / Invesco Exchange-Traded Fund Trust II - Invesco Nasdaq Biotechnology ETF
InstitutionClarius Group, LLC
Latest Disclosed Ownership19,396 shares
Latest Disclosed Value $ 550,768
Clarius Group, LLC reports 0.32% increase in ownership of IBBQ / Invesco Exchange-Traded Fund Trust II - Invesco Nasdaq Biotechnology ETF

On January 14, 2026 - Clarius Group, LLC filed a 13F-HR form disclosing ownership of 19,396 shares of Invesco Exchange-Traded Fund Trust II - Invesco Nasdaq Biotechnology ETF (US:IBBQ) valued at $550,773 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 14, 2025 disclosing 19,335 shares of Invesco Exchange-Traded Fund Trust II - Invesco Nasdaq Biotechnology ETF. This represents a change in shares of 0.32% during the quarter. The current value of the position is $564,268 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-14 2025-12-31 13F INVESCO EXCH TRADED FD TR II NASDAQ BIOTECH 46138G599 19,396 61 0.32 551 17.02 0.0314
2025-10-14 2025-09-30 13F INVESCO EXCH TRADED FD TR II NASDAQ BIOTECH 46138G599 19,335 78 0.41 470 15.76 0.0278
2025-07-22 2025-06-30 13F INVESCO EXCH TRADED FD TR II NASDAQ BIOTECH 46138G599 19,257 26 0.14 407 -0.25 0.0237
2025-04-18 2025-03-31 13F INVESCO EXCH TRADED FD TR II NASDAQ BIOTECH 46138G599 19,231 35 0.18 408 -1.45 0.0256
2025-01-16 2024-12-31 13F INVESCO EXCH TRADED FD TR II NASDAQ BIOTECH 46138G599 19,196 54 0.28 413 -9.23 0.0282
2024-10-09 2024-09-30 13F INVESCO EXCH TRADED FD TR II NASDAQ BIOTECH 46138G599 19,142 72 0.38 455 4.84 0.0319
2024-07-11 2024-06-30 13F INVESCO EXCH TRADED FD TR II NASDAQ BIOTECH 46138G599 19,070 42 0.22 434 2.84 0.0308
2024-04-17 2024-03-31 13F INVESCO EXCH TRADED FD TR II NASDAQ BIOTECH 46138G599 19,028 38 0.20 422 1.69 0.0291
2024-01-29 2023-12-31 13F INVESCO EXCH TRADED FD TR II NASDAQ BIOTECH 46138G599 18,990 46 0.24 416 10.67 0.0345
2023-10-19 2023-09-30 13F INVESCO EXCH TRADED FD TR II NASDAQ BIOTECH 46138G599 18,944 39 0.21 375 -2.85 0.0358
2023-08-10 2023-06-30 13F INVESCO EXCH TRADED FD TR II NASDAQ BIOTECH 46138G599 18,905 42 0.22 386 -1.03 0.0299
2023-04-17 2023-03-31 13F INVESCO EXCH TRADED FD TR II NASDAQ BIOTECH 46138G599 18,863 35 0.19 390 0.0331
2023-01-25 2022-12-31 13F INVESCO EXCH TRADED FD TR II NASDAQ BIOTECH 46138G599 18,828 38 0.20 0 -100.00 0.0358
2022-10-24 2022-09-30 13F INVESCO EXCH TRADED FD TR II NASDAQ BIOTECH 46138G599 18,790 38 0.20 356 0.85 0.0356
2022-08-10 2022-06-30 13F INVESCO EXCH TRADED FD TR II NASDAQ BIOTECH 46138G599 18,752 0 0.00 353 -20.67 0.0352
2022-04-08 2022-03-31 13F INVESCO EXCH TRADED FD TR II NASDAQ BIOTECH 46138G599 18,752 0 0.00 445 0.00 0.0352
2022-02-02 2021-12-31 13F INVESCO EXCH TRADED FD TR II NASDAQ BIOTECH 46138G599 18,752 0 0.00 445 -7.29 0.0352
2021-10-18 2021-09-30 13F INVESCO EXCH TRADED FD TR II NASDAQ BIOTECH 46138G599 18,752 18,752 480 0.0430
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.